Cue Biopharma

Cue Biopharma CUE Stock

$4.76   68.197890%
Add to favorites
Market Cap
$39.79M
LOW - HIGH [24H]
$3.27 - $4.77
VOLUME [24H]
$12.41M
P/E Ratio
0
Earnings per share
-$27.80
ISIN
US22978P1066
Price   Prediction

Cue Biopharma Price Chart

Sorry, that's all we've gotfor now...

Cue Biopharma (CUE) stock price today is 4.76 USD on Tech Market Small (+68.2% on the day). Updated .

Cue Biopharma CUE Financial and Trading Overview

Cue Biopharma stock price 4.76 USD
Previous Close 2.83 USD
Open 3.4 USD
Bid 3.85 USD x 100
Ask 5.77 USD x 200
Day's Range 3.27 - 4.69 USD
52 Week Range 2.83 - 45.5 USD
Volume 11.82M USD
Avg. Volume 314.1K USD
Market Cap 37.79M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -27.8 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 68.67 USD

CUE Valuation Measures

Enterprise Value -34328548 USD
Trailing P/E N/A
Forward P/E -9.416667
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.0602459
Price/Book (mrq) 0.91276246
Enterprise Value/Revenue -0.963
Enterprise Value/EBITDA 0.251

Trading Information

Cue Biopharma Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -83.73%
S&P500 52-Week Change 10.51%
52 Week High 45.5 USD
52 Week Low 2.83 USD
50-Day Moving Average 23.13 USD
200-Day Moving Average 21.55 USD

CUE Share Statistics

Avg. Volume (3 month) 314.1K USD
Avg. Daily Volume (10-Days) 571.06K USD
Shares Outstanding 8.36M
Float 7.32M
Short Ratio 5.12
% Held by Insiders 13.08%
% Held by Institutions 54.69%
Shares Short 862.8K
Short % of Float 11.65%
Short % of Shares Outstanding 11.12%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor 1:30

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -386.69%
Gross Margin 55.57%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -174.17%
Return on Equity (ttm) -800.38%

Income Statement

Revenue (ttm) 35.64M USD
Revenue Per Share (ttm) 5.62 USD
Quarterly Revenue Growth (yoy) -93.89%
Gross Profit (ttm) 19.81M USD
EBITDA -136496000 USD
Net Income Avi to Common (ttm) -206676000 USD
Diluted EPS (ttm) -27.8
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 57.99M USD
Total Cash Per Share (mrq) 6.94 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 3.382
Book Value Per Share (mrq) 4.952

Cash Flow Statement

Operating Cash Flow (ttm) -51104000 USD
Levered Free Cash Flow (ttm) -76024248 USD

Profile of Cue Biopharma

Country United States
State MA
City Boston
Address 40 Guest Street
ZIP 02135
Phone 617 949 2680
Website https://www.cuebiopharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 29

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Q&A For Cue Biopharma Stock

What is a current CUE stock price?

Cue Biopharma CUE stock price today per share is 4.76 USD.

How to purchase Cue Biopharma stock?

You can buy CUE shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Cue Biopharma?

The stock symbol or ticker of Cue Biopharma is CUE.

Which industry does the Cue Biopharma company belong to?

The Cue Biopharma industry is Biotechnology.

How many shares does Cue Biopharma have in circulation?

The max supply of Cue Biopharma shares is 8.36M.

What is Cue Biopharma Price to Earnings Ratio (PE Ratio)?

Cue Biopharma PE Ratio is now.

What was Cue Biopharma earnings per share over the trailing 12 months (TTM)?

Cue Biopharma EPS is -27.8 USD over the trailing 12 months.

Which sector does the Cue Biopharma company belong to?

The Cue Biopharma sector is Healthcare.

Cue Biopharma CUE included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24429.89 USD —
+0.42
6.99B USD — 24225.3 USD — 24538.78 USD — — 6.99B USD —
us US Tech Capital Market Composite RCMP US 108.78 USD —
+0.08
— — 108.35 USD — 109.95 USD — — — —
us US Tech Health Care IXHC US 1324.44 USD —
-0.63
— — 1322.85 USD — 1342.46 USD — — — —
$2.17T
Total marketcap
$71.11B
Total volume
BTC 57.99%   •   ETH 9.91%
Dominance
Select currency